Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging miR‐28‐5p/STK4 axis and inactivating Wnt/β‐catenin signaling

BACKGROUND: Ginsenoside Rh2 (G‐Rh2) exerts anti‐tumor activity in non‐small cell lung cancer (NSCLC). microRNAs (miRNAs, miRs) play pivotal roles in NSCLC. We aimed to investigate whether G‐Rh2 inhibited NSCLC progression by targeting miRNA. METHODS: Cell viability, apoptosis and cycle were determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jun, Zhao, Di, Yu, Dahai, Song, Wei, Yang, Xiaofang, Yin, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278491/
https://www.ncbi.nlm.nih.gov/pubmed/37081781
http://dx.doi.org/10.1002/cam4.5960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278491/
https://www.ncbi.nlm.nih.gov/pubmed/37081781
http://dx.doi.org/10.1002/cam4.5960

Ejemplares similares